{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein is associated with Parkinson's disease (PD) pathogenesis, evidenced by single point mutations and gene duplication/triplication linked to early-onset familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay for the A30P variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used single-molecule FRET (smFRET) and ensemble (far-UV CD) measurements to probe the effects of mutations on the coupled binding and folding of a-synuclein.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models the disease pathogenesis/mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study included controls and replicates, and the specific instance of the assay has been previously validated.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, and the assay has been previously validated.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared the A30P mutant with wild-type a-synuclein and other PD-linked mutants (A53T, E46K).",
          "judgment": "Yes",
          "reasoning": "Variant controls were used, including known pathogenic variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The A30P mutation significantly perturbs the binding-folding thermodynamics of a-synuclein, favoring the bent helical structure over the extended helix structure.",
          "judgment": "Yes",
          "reasoning": "The statistical analyses and results strongly support the pathogenic nature of the A30P mutation.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The A30P mutation's effects on a-synuclein's conformational properties are significant, supporting its pathogenic role.",
          "judgment": "Yes",
          "reasoning": "The evidence strongly supports the pathogenic nature of the A30P mutation, aligning with PS3_very_strong criteria.",
          "next_step_or_outcome": "Finalize evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The A30P mutation in SNCA significantly alters the binding-folding thermodynamics of a-synuclein, favoring a conformation linked to PD pathogenesis, supporting a PS3_very_strong rating."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein is associated with Parkinson's disease (PD) pathogenesis, evidenced by single point mutations and gene duplication/triplication linked to early-onset familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay for the A53T variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used single-molecule FRET (smFRET) and ensemble (far-UV CD) measurements to probe the effects of mutations on the coupled binding and folding of a-synuclein.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models the disease pathogenesis/mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study included controls and replicates, and the specific instance of the assay has been previously validated.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, and the assay has been previously validated.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared the A53T mutant with wild-type a-synuclein and other PD-linked mutants (A30P, E46K).",
          "judgment": "Yes",
          "reasoning": "Variant controls were used, including known pathogenic variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The A53T mutant maintained the three-state thermal-unfolding behavior exhibited by WT a-synuclein.",
          "judgment": "No",
          "reasoning": "The A53T mutation does not significantly alter the binding-folding thermodynamics of a-synuclein, suggesting a less direct pathogenic role.",
          "next_step_or_outcome": "Finalize evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T mutation in SNCA does not significantly alter the binding-folding thermodynamics of a-synuclein, supporting a PS3_supporting rating due to its less direct pathogenic role."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein is associated with Parkinson's disease (PD) pathogenesis, evidenced by single point mutations and gene duplication/triplication linked to early-onset familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay for the E46K variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used single-molecule FRET (smFRET) and ensemble (far-UV CD) measurements to probe the effects of mutations on the coupled binding and folding of a-synuclein.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models the disease pathogenesis/mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study included controls and replicates, and the specific instance of the assay has been previously validated.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, and the assay has been previously validated.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared the E46K mutant with wild-type a-synuclein and other PD-linked mutants (A30P, A53T).",
          "judgment": "Yes",
          "reasoning": "Variant controls were used, including known pathogenic variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The E46K mutant maintained the three-state thermal-unfolding behavior exhibited by WT a-synuclein.",
          "judgment": "No",
          "reasoning": "The E46K mutation does not significantly alter the binding-folding thermodynamics of a-synuclein, suggesting a less direct pathogenic role.",
          "next_step_or_outcome": "Finalize evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E46K mutation in SNCA does not significantly alter the binding-folding thermodynamics of a-synuclein, supporting a PS3_supporting rating due to its less direct pathogenic role."
    }
  ]
}